Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2390 (LINC02390) is a human gene that encodes a transcript classified as a **long intergenic non-coding RNA (lincRNA)**, which means its RNA product is longer than 200 nucleotides, does not overlap with protein-coding genes, and does not encode a functional protein[1][3][5]. LincRNAs such as LINC02390 can regulate gene expression through multiple mechanisms, including chromatin remodeling, acting as enhancers, influencing transcription in cis or trans, and interacting with RNA or protein complexes[3][7]. LINC02390 is not classified as a therapeutic target (i.e., receptor, enzyme, transporter), but it may play roles in fine-tuning gene regulation and is part of the growing catalog of non-coding RNAs potentially relevant for disease research or biomarker discovery[1][3][7]. There is currently **no direct evidence** linking LINC02390 to drugs, mechanisms of action, or well-validated roles in disease, and it is primarily of interest as a non-coding regulatory RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2390 (LINC02390).